Shopping Cart
- Remove All
- Your shopping cart is currently empty
CDK4/6-IN-7, a highly potent and selective orally active inhibitor of CDK4/6, demonstrates impressive inhibition activity with IC50 values of 1.58 nM and 4.09 nM respectively. This compound is particularly valuable for breast cancer research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | CDK4/6-IN-7, a highly potent and selective orally active inhibitor of CDK4/6, demonstrates impressive inhibition activity with IC50 values of 1.58 nM and 4.09 nM respectively. This compound is particularly valuable for breast cancer research [1]. |
In vitro | CDK4/6-IN-7 (compound 7c) impairs MCF-7 cell viability with an IC₅₀ value of 0.92 μM after 48 hours of exposure to concentrations ranging from 0.1 to 656.1 μM, as observed in a cell proliferation assay [1]. |
In vivo | CDK4/6-IN-7 (compound 7c), when administered orally at 50 mg/kg daily for seven days, significantly inhibits tumor growth with a 57.68% inhibition rate in MCF-7 tumor-bearing female nude mice (aged 5 weeks), demonstrating both efficacy and tolerability. |
Molecular Weight | 387.82 |
Formula | C18H18ClN5O3 |
Cas No. | 2649120-20-5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.